Suppr超能文献

泛素连接酶 Ube3a 的功能障碍可能与亨廷顿病小鼠模型中的突触病理生理学有关。

Dysfunction of the ubiquitin ligase Ube3a may be associated with synaptic pathophysiology in a mouse model of Huntington disease.

机构信息

Cellular and Molecular Neuroscience Laboratory, National Brain Research Centre, Manesar, Gurgaon, Haryana 122050, India.

出版信息

J Biol Chem. 2012 Aug 24;287(35):29949-57. doi: 10.1074/jbc.M112.371724. Epub 2012 Jul 11.

Abstract

Huntington disease (HD) is a hereditary neurodegenerative disorder characterized by progressive cognitive, psychiatric, and motor symptoms. The disease is caused by abnormal expansion of CAG repeats in the gene encoding huntingtin, but how mutant huntingtin leads to early cognitive deficits in HD is poorly understood. Here, we demonstrate that the ubiquitin ligase Ube3a, which is implicated in synaptic plasticity and involved in the clearance of misfolded polyglutamine protein, is strongly recruited to the mutant huntingtin nuclear aggregates, resulting in significant loss of its functional pool in different regions of HD mouse brain. Interestingly, Arc, one of the substrates of Ube3a linked with synaptic plasticity, is also associated with nuclear aggregates, although its synaptic level is increased in the hippocampus and cortex of HD mouse brain. Different regions of HD mouse brain also exhibit decreased levels of AMPA receptors and various pre- and postsynaptic proteins, which could be due to the partial loss of function of Ube3a. Transient expression of mutant huntingtin in mouse primary cortical neurons further demonstrates recruitment of Ube3a into mutant huntingtin aggregates, increased accumulation of Arc, and decreased numbers of GluR1 puncta in the neuronal processes. Altogether, our results suggest that the loss of function of Ube3a might be associated with the synaptic abnormalities observed in HD.

摘要

亨廷顿病(HD)是一种遗传性神经退行性疾病,其特征是进行性认知、精神和运动症状。该疾病是由编码亨廷顿蛋白的基因中 CAG 重复序列的异常扩展引起的,但突变亨廷顿蛋白如何导致 HD 中的早期认知缺陷尚不清楚。在这里,我们证明了泛素连接酶 Ube3a 强烈募集到突变的亨廷顿蛋白核聚集体中,导致其在不同的 HD 小鼠脑区中的功能池显著丧失,Ube3a 涉及突触可塑性,与异常折叠的多聚谷氨酰胺蛋白的清除有关。有趣的是,Arc 是与突触可塑性相关的 Ube3a 的底物之一,也与核聚集体相关,尽管其突触水平在 HD 小鼠脑的海马体和皮质中增加。HD 小鼠脑的不同区域还表现出 AMPA 受体和各种前突触和后突触蛋白水平降低,这可能是由于 Ube3a 的部分功能丧失。突变型亨廷顿蛋白在小鼠原代皮质神经元中的瞬时表达进一步证明了 Ube3a 被募集到突变型亨廷顿蛋白聚集体中,Arc 的积累增加,神经元过程中的 GluR1 点状结构减少。总之,我们的结果表明,Ube3a 的功能丧失可能与 HD 中观察到的突触异常有关。

相似文献

1
Dysfunction of the ubiquitin ligase Ube3a may be associated with synaptic pathophysiology in a mouse model of Huntington disease.
J Biol Chem. 2012 Aug 24;287(35):29949-57. doi: 10.1074/jbc.M112.371724. Epub 2012 Jul 11.
2
Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1035-45. doi: 10.1098/rstb.1999.0456.
3
Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice.
J Cell Biol. 2008 Mar 24;180(6):1177-89. doi: 10.1083/jcb.200709080.
4
Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease.
Hum Mol Genet. 2006 May 15;15(10):1690-703. doi: 10.1093/hmg/ddl092. Epub 2006 Apr 6.
5
Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load.
J Physiol. 2007 Dec 15;585(Pt 3):817-31. doi: 10.1113/jphysiol.2007.142448. Epub 2007 Oct 18.
6
Deficiency of Ube3a in Huntington's disease mice brain increases aggregate load and accelerates disease pathology.
Hum Mol Genet. 2014 Dec 1;23(23):6235-45. doi: 10.1093/hmg/ddu343. Epub 2014 Jul 4.
8
Azadiradione Restores Protein Quality Control and Ameliorates the Disease Pathogenesis in a Mouse Model of Huntington's Disease.
Mol Neurobiol. 2018 Aug;55(8):6337-6346. doi: 10.1007/s12035-017-0853-3. Epub 2018 Jan 2.
9
Super-resolution imaging reveals extrastriatal synaptic dysfunction in presymptomatic Huntington disease mice.
Neurobiol Dis. 2021 May;152:105293. doi: 10.1016/j.nbd.2021.105293. Epub 2021 Feb 5.

引用本文的文献

1
The autism-associated loss of δ-catenin functions disrupts social behavior.
Proc Natl Acad Sci U S A. 2023 May 30;120(22):e2300773120. doi: 10.1073/pnas.2300773120. Epub 2023 May 22.
2
Ubiquitin-modifying enzymes in Huntington's disease.
Front Mol Biosci. 2023 Feb 8;10:1107323. doi: 10.3389/fmolb.2023.1107323. eCollection 2023.
3
Molecular Pathophysiological Mechanisms in Huntington's Disease.
Biomedicines. 2022 Jun 17;10(6):1432. doi: 10.3390/biomedicines10061432.
5
Ubiquitin signaling in neurodegenerative diseases: an autophagy and proteasome perspective.
Cell Death Differ. 2021 Feb;28(2):439-454. doi: 10.1038/s41418-020-00667-x. Epub 2020 Nov 18.
6
LRSAM1 E3 ubiquitin ligase: molecular neurobiological perspectives linked with brain diseases.
Cell Mol Life Sci. 2019 Jun;76(11):2093-2110. doi: 10.1007/s00018-019-03055-y. Epub 2019 Mar 2.
7
UBE3A regulates the transcription of IRF, an antiviral immunity.
Hum Mol Genet. 2019 Jun 15;28(12):1947-1958. doi: 10.1093/hmg/ddz019.
8
Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.
Acta Pharmacol Sin. 2018 May;39(5):754-769. doi: 10.1038/aps.2018.11. Epub 2018 Apr 5.
9
Azadiradione Restores Protein Quality Control and Ameliorates the Disease Pathogenesis in a Mouse Model of Huntington's Disease.
Mol Neurobiol. 2018 Aug;55(8):6337-6346. doi: 10.1007/s12035-017-0853-3. Epub 2018 Jan 2.
10
Ubiquitin-proteasome system involvement in Huntington's disease.
Front Mol Neurosci. 2014 Sep 29;7:77. doi: 10.3389/fnmol.2014.00077. eCollection 2014.

本文引用的文献

1
Impaired alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor trafficking and function by mutant huntingtin.
J Biol Chem. 2011 Sep 30;286(39):33719-28. doi: 10.1074/jbc.M111.236521. Epub 2011 Aug 5.
2
Brief ampakine treatments slow the progression of Huntington's disease phenotypes in R6/2 mice.
Neurobiol Dis. 2011 Feb;41(2):436-44. doi: 10.1016/j.nbd.2010.10.015. Epub 2010 Oct 23.
3
Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease.
Trends Neurosci. 2010 Nov;33(11):513-23. doi: 10.1016/j.tins.2010.08.002. Epub 2010 Sep 17.
4
Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome.
Neurobiol Dis. 2010 Dec;40(3):586-92. doi: 10.1016/j.nbd.2010.08.002. Epub 2010 Aug 6.
5
Cognitive and functional decline in Huntington's disease: dementia criteria revisited.
Mov Disord. 2010 Jul 15;25(9):1163-9. doi: 10.1002/mds.22953.
6
Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.
Neurobiol Dis. 2010 Sep;39(3):283-91. doi: 10.1016/j.nbd.2010.04.012. Epub 2010 Apr 25.
7
Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a.
Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5611-6. doi: 10.1073/pnas.1001281107. Epub 2010 Mar 8.
8
The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc.
Cell. 2010 Mar 5;140(5):704-16. doi: 10.1016/j.cell.2010.01.026.
10
Co-chaperone CHIP stabilizes aggregate-prone malin, a ubiquitin ligase mutated in Lafora disease.
J Biol Chem. 2010 Jan 8;285(2):1404-13. doi: 10.1074/jbc.M109.006312. Epub 2009 Nov 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验